003f7587763e4e8cb091c44d930e29630908d22796854988a2f91806af9cecd1123ed56f626042f5b2e38e6da1379c4924e67315cadf46ce96157a8c67a31dfd3720d3d5d74942d684771ff45fc28c30382959f5ce71421e81ad929ae461d3ad4d965a00a4a245f7b6a88f94d08657db548459d99a6741208cfe9b1bb8b0d1b2675f681c6ba94f9785e1064f4cef399d749ce7f61b044ba9846daaf3c3f8da7f88831cb497c14db4a9acba77585ee0728b3046327f5740b9b5532b92dd3cf93dfbf38a3da49d41c392562bda0235abf4fdee28c18184453bb4dc0d7f902871f1
agent
Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy responsePlasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell CapacityLong-term expanding human airway organoids for disease modelingTowards personalized therapy in pediatric acute lymphoblastic leukemiaDifferential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell MicroenvironmentsSimultaneous detection of clinically relevant mutations and amplifications for routine cancer pathologyPreserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastasesGeneration of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor OrganoidsGenomic and transcriptomic plasticity in treatment-naive ovarian cancerIntravital characterization of tumor cell migration in pancreatic cancerDetailed imaging and genetic analysis reveal a secondary BRAF(L) (505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenibPatient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientsEffective Therapeutic Intervention and Comprehensive Genetic Analysis of mTOR Signaling in PEComaChallenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine
author
nationality
type
label
Emile E Voest